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National  Comprehensive  Cancer  Control  Program  (NCCCP)
awardees are encouraged to work with partners (eg, nonprofit or-
ganizations) to develop and implement plans to reduce the cancer
burden  in  their  jurisdictions  using  evidence-based  practices
(EBPs).  However,  the extent of EBP use among awardees and
their partners is not well understood.
Methods
From March through July 2012, we conducted a web-based sur-
vey of program partners referred by NCCCP program directors
who were involved in implementation of cancer control plans.
Results
Approximately 53% of referred partners (n = 83) completed sur-
veys, 91.6% of whom represented organizations. Most partners re-
ported involvement in helping to identify (80.5%), adapt (81.7%),
implement (90.4%), and evaluate (81.9%) EBPs. The factors rated
most  frequently  as  very  important  when selecting  EBPs were
“consistent with our organization’s mission” (89.2%) and “cost-ef-
fective” (81.9%). Although most respondents said that their organ-
izations understood the importance of using EBPs (84.3%) and
had adequate access to cancer registry data (74.7%), few reported
having sufficient financial resources to develop new EBPs (7.9%).
The most frequently mentioned benefit of using EBPs was that
they are proven to work.  Resource limitations and difficulty ad-
apting EBPs for specific populations and settings were challenges.
Conclusions
Our findings help indicate how NCCCP partners are involved in
using EBPs and can guide ongoing efforts to encourage the use of
EBPs for cancer control. The challenges of using EBPs that part-
ners identified highlight the need to improve strategies to translate
cancer prevention and control research into practice in real-world
settings and for diverse populations.
Introduction
Comprehensive cancer control (CCC) is a collaborative process
through which a community and its partners pool financial and
nonfinancial resources to reduce the burden of cancer (1). The Na-
tional Comprehensive Cancer Control Program (NCCCP), funded
by  the  Centers  for  Disease  Control  and  Prevention  (CDC),
provides technical support to CCC programs in 50 states, the Dis-
trict of Columbia, 7 US Associated Pacific Islands (USAPI)/territ-
ories, and 7 tribes or tribal organizations to develop, implement,
and evaluate plans to prevent and control cancer in their jurisdic-
tions. The NCCCP encourages CCC programs to work with coali-
tions, program stakeholders, or other partnerships to help conduct
these activities (2). Partners may include health systems and non-
profit organizations and may be structured as part of health depart-
ments, 501(c)3 organizations, academic institutions, or cancer cen-
ters (3).
The NCCCP promotes the use of evidence-based practices (EBPs)
for the development and implementation of cancer control plans
and encourages grantees to use high-quality data and research to
assess the burden of cancer in their jurisdictions, set priorities, and
develop program goals (4–6). EBPs are defined as public health
practices (interventions, programs, strategies, policies, procedures,
processes, or activities) that have been tested or evaluated and
shown to be effective; this definition is based on concepts of evid-
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ence-based public health (7–9). CCC partners have diverse skills
and expertise that place them in a unique position to encourage the
use of cancer-related EBPs (eg, cancer prevention and early detec-
tion interventions in the Guide to Community Preventive Services)
by CCC programs (10,11). Many CCC partnerships include a core
group of local organizations and individuals who provide coali-
tion leadership and take responsibility for selected activities, a
convening organization that coordinates activities and monitors
the jurisdiction’s cancer burden, and a broad partnership that is
dedicated to implementing the jurisdiction’s cancer control plan
(11).
The extent of EBP use among CCC programs is not well under-
stood, and little is known about the experiences of CCC programs
and their partners in identifying and using EBPs (3,10,12,13). Po-
tential barriers to the adoption of an EBP include characteristics of
the practice as well as the organization that decides whether to ad-
opt it (14,15). To address this gap, 2 surveys — one of CCC pro-
gram directors and one of partners — were conducted to examine
the use of scientific and practice-based information to inform de-
velopment of cancer control plans and select evidence-based inter-
ventions. Findings from the survey of program directors have been
published (16). The purposes of this study were to assess the part-
ners’ perceptions of and roles in using EBPs for CCC with the aim
of improving technical support to CCC programs related to identi-
fying, adapting, implementing, and evaluating EBPs. This study
was declared exempt from review by Battelle Memorial Institute’s
institutional review board and was approved by the Office of Man-
agement and Budget (control no. 0920–0921).
Methods
From March through July 2012, we conducted a cross-sectional
survey targeting a convenience sample of up to 4 program part-
ners referred by each of the CCC program directors who particip-
ated in the survey of directors. Program directors were asked to
refer partners who were instrumental to the selection and imple-
mentation of cancer control EBPs in their jurisdictions. We in-
cluded the 65 CCC programs that receive funding from CDC as
well as CCC programs in 4 constituent states (Yap, Chuuk, Pohn-
pei, and Kosrae) supported by the national program in the Feder-
ated States of  Micronesia.  Therefore,  partners of  69 programs
were eligible to participate in this study. Recruitment for the part-
ner survey began as soon as the program directors (or their design-
ees) began providing their names and contact information. This in-
formation was entered into a survey tracking system, which was
linked to the Web survey software and generated recruitment and
reminder and follow-up email messages.
Survey measures were based on concepts from diffusion of innov-
ations theory and dissemination science (14,17,18). Diffusion of
innovations is defined as the process by which an innovation is
communicated through certain channels over time among mem-
bers of a social system (18). Characteristics of public health innov-
ations that affect their rate of adoption include relative advantage,
compatibility, complexity, and reinvention. We were also guided
by a questionnaire developed by Hannon and colleagues to assess
use of EBPs among members of the Cancer Prevention and Con-
trol Research Network (13). Our final variables and questionnaire
items were designed to address use of EBPs and EBP resources
(eg, the Guide to Community Preventive Services, Cancer Control
P.L.A.N.E.T., Research-Tested Intervention Programs) (19–21),
knowledge and attitudes about EBPs, characteristics of respond-
ents and respondent organizations, and technical assistance needs
of CCC program staff.
The Web-based,  self-administered survey consisted of  mostly
close-ended, structured items. The questions were similar to those
used in the questionnaire for program directors, but there were
fewer total items. We used 2 open-ended questions to assess part-
ners’ perceptions about benefits and challenges of using EBPs for
cancer control. To understand how partners help CCC programs
use EBPs, we asked about their involvement in 4 core activities re-
lated to using EBPs:  identifying,  adapting,  implementing,  and
evaluating. To assess what characteristics or other factors are per-
ceived as important when choosing EBPs in their jurisdictions and
communities, we asked respondents to use a 4-point scale (very
important, somewhat important, moderately important, not at all
important) to rate the importance of a series of 14 items represent-
ing different aspects of EBPs. We also included questions inten-
ded to measure partners’ perceptions about their organizations’ ca-
pacities for using EBPs for cancer control. They were asked to in-
dicate their level of agreement (strongly disagree, disagree, neither
agree nor disagree, agree, strongly agree) with 11 statements rep-
resenting organizational characteristics that could facilitate use of
EBPs. To obtain feedback on the format and relevance of survey
questions, as well as to estimate the time required to complete the
survey, the questionnaire was pilot-tested with 6 partners referred
by 3 program directors from a state, a tribe, and a territory. The
questionnaire  was  modified  based  on  findings  from the  pilot;
therefore, the final analysis excludes pilot data. After excluding
programs that piloted data (n = 3) and that opted not to participate
in the study (n = 5) from the 69 programs eligible to participate,
the total number of programs that referred partners was 61. The fi-
nal instrument consisted of 40 questions. The partners received re-
minder emails and postcards if they did not complete their sur-
veys.
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Stata version 11 (StataCorp LP) was used for data analysis, includ-
ing univariate analyses and exploratory bivariate analyses examin-
ing relationships between selected categorical variables via cross-
tabulations. We used qualitative content analysis methods (22,23)
using  NVivo  (version  9,  QSR  International)  to  examine  key
themes in the open-ended questions.
Results
Of 158 partners who were referred by NCCCP program directors
and sent invitations to participate in the survey, 83 completed sur-
veys (response rate, 52.5%). The participating partners included
70 who were affiliated with state programs, 9 with USAPI/territor-
ies programs, and 4 with tribal or tribal organization programs.
Most  partners  represented  organizations,  including  voluntary
health organizations, community-based or nonprofit organizations,
health care systems, and local health departments. Nearly two-
thirds of the respondents had graduate or professional degrees, and
more than half had been working with the CCC programs in their
jurisdictions for more than 5 years.
Most partners reported involvement in each of 4 core activities re-
lated to using EBPs (Table 1). The activity with the highest repor-
ted level of involvement was implementation of EBPs (90.4%);
partners involved in identifying, adapting, and evaluating EBPs
were nearly the same (80.5%–81.9%). Most partners were confid-
ent in their abilities to carry out these activities; approximately
90% were totally or somewhat confident that they could 1) assess
whether certain EBPs are appropriate for use by the CCC pro-
grams in their jurisdictions, 2) find EBPs that could be used by the
programs, and 3) adapt EBPs for specific populations or settings in
their jurisdictions. Many were also confident that they could im-
plement (83.1%) and evaluate (84.3%) EBPs.
The characteristics rated most frequently as very important when
choosing EBPs were “consistent with our organization’s mission”
(89.2%), “cost-effective” (81.9%), “scientific evidence indicates
EBPs work” (78.3%), and “easy to implement” (72.3%) (Table 2).
Overall, most respondents strongly agreed or agreed with most
statements about organizational characteristics that could encour-
age EBP use, including “my CCC organization understands the
importance of using EBPs” (84.3%), “my CCC organization has
adequate access to cancer registry data” (74.7%), and “using EBPs
is part of the norm in my CCC organization” (74.7%) (Table 3). A
much smaller percentage of partners strongly agreed or agreed that
their organizations had sufficient staffing to develop new EBPs
(27.7%) or financial resources for both the development of new
EBPs (7.9%) and implementation of existing EBPs (23.7%).
We grouped the most frequently reported benefits of using EBPs
into the following categories: proven to work, measurability, cost-
effectiveness, credibility with funders and coalitions, recommen-
ded by funders, provide community benefits, and availability of
technical assistance. The most frequently mentioned benefit of us-
ing EBPs was that they are proven to work, which some respond-
ents associated with increasing the likelihood of successful out-
comes. Many respondents said that EBPs provide a scientific basis
for measuring and evaluating program impact, are replicable, and
can be adapted. Some respondents noted that using EBPs is an ef-
ficient use of resources because programs do not have to spend
funds developing and testing interventions. Other perceived bene-
fits were that EBPs come with technical assistance, and their use
increases the credibility of CCC programs among community part-
ners and sponsoring agencies.
We also grouped perceived challenges of using EBPs into several
categories,  including resource limitations;  lack of  appropriate
EBPs for specific populations and communities; adapting, imple-
menting, and evaluating EBPs; and obtaining community buy-in.
Most respondents identified resource limitations as a barrier, in-
cluding lack of funds to develop and test interventions and adapt
materials. Some respondents who said that EBPs may not be a
good fit for specific populations noted that sufficient evidence was
lacking for these groups because the EBPs had not been field-
tested in their communities. Barriers related to adapting EBPs in-
cluded uncertainty  about  maintaining fidelity  when evidence-
based interventions are implemented, lack of technical support,
and difficulties tailoring interventions for populations that may not
“trust government or science.” A few respondents said that imple-
menting and evaluating EBPs were challenging and that multicom-
ponent interventions were costly. Others commented that evaluat-
ing and measuring outcomes for EBPs that had been tested in re-
search rather than real-world settings was difficult. One respond-
ent noted that it would be useful to have logic models for EBPs
that list resources needed, key activities, and evaluation steps.
Discussion
This is the first study to comprehensively and specifically assess
perceptions about EBPs among selected partners of NCCCP-fun-
ded programs, as well as their roles and responsibilities in using
EBPs for developing and implementing cancer control plans. In
2009, NCCCP programs reported that they were working in part-
nership with more than 6,000 organizations and individuals, in-
cluding  government  public  health  programs  (94%),  academic
(94%) and professional  (84%) organizations,  cancer survivors
(63%), and political leaders (51%) (11). The programs often lever-
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age the resources of these partners (eg, donated time, financial
support, subject matter expertise) to develop and implement inter-
ventions in cancer control plans (24); therefore, CCC partners are
crucial to accelerating the adoption of EBPs.
More than 90% of partners reported involvement in implementing
EBPs. This percentage is higher than the level of partner involve-
ment in implementing interventions reported by NCCCP program
directors in previous studies. Townsend and colleagues evaluated
performance measures data reported by NCCCP awardees to CDC
as a condition of their funding (24). In their analysis, 60% of pro-
grams reported that their partners had implemented at least one
priority strategy from their jurisdiction’s cancer control plan from
June 2008 through June 2009. Rochester and colleagues, in their
pilot test of a 2007 NCCCP grantee performance measurement
worksheet, also reported that 60% of programs indicated that their
partners had implemented interventions (25). These discrepancies
may be related to the fact that we asked CCC program directors to
refer partners who collaborate with them in the selection and use
of EBPs, thus providing us with a sampling pool more likely to in-
clude partners involved with implementation. Additionally, the
Townsend and Rochester studies assessed all interventions repor-
ted by programs, not just those that were evidence-based. The dif-
ferences in findings could also reflect an increase in partner in-
volvement with EBP implementation over time — our survey was
conducted more recently, and the performance measures for the
current NCCCP project period (2012–2017) place a greater em-
phasis on collaborating with partners by forming coalition and
partner workgroups to implement interventions and coordinate
with other chronic disease prevention programs (24).
The percentages of partners who rated various characteristics as
very important in the selection of EBPs are similar to the percent-
ages of NCCCP program directors who selected this rating for the
same characteristics (16). These rankings are also similar to those
reported by cancer control planners who participated in a study by
Hannon and colleagues (13). In that study, participants said con-
sistency with their organization’s mission, cost-effectiveness, and
evidence for the overall effectiveness of a program were import-
ant in selecting evidence-based programs. Many of these factors
(eg, cost-effectiveness, ease of implementation, compatibility with
an organization’s mission) have been reported in some translation
and dissemination studies to predict successful adoption of EBPs
(14,26). However, the importance of these attributes in the use of
EBPs may vary by setting (14). Viewed through the lenses of dif-
fusion of innovations theory and dissemination science, the inter-
action among intervention characteristics, the intended adopters,
and organizational context or features determine adoption and im-
plementation of EBPs (14,15).
We found substantial differences in perceptions about organiza-
tional capacity for using EBPs. Although most respondents indic-
ated that their organizations had sufficient access to cancer sur-
veillance data, community advisors, and epidemiologic support,
many reported limited financial and staffing resources. Some CCC
partner organizations receive financial assistance from CCC pro-
grams to help implement cancer plans; nearly one-third of NC-
CCP program directors reported that they provide funding and oth-
er support to their partners for CCC activities (16). The CCC Na-
tional Partnership, a collaborative group of diverse national organ-
izations, also provides financial resources to CCC coalitions and
partnerships (27). Collaboration and leveraging shared resources
are embodied in the definition of CCC, and both are critical to sus-
taining efforts by communities and their partners to reduce the
burden of cancer.
The benefits of using EBPs that the partners identified were simil-
ar to those reported by CCC program directors (16). The most fre-
quently reported benefit for both groups was that EBPs have been
proven to work. Many also indicated that EBPs are measurable.
Systematic reviews of evidence-based interventions to prevent and
control chronic disease are available at no cost to cancer control
planners on Web portals such as Cancer Control P.L.A.N.E.T (20).
Because evidence gaps remain for some strategies, the reviews are
updated periodically to identify new studies and determine wheth-
er additional evidence would change existing recommendations
(28). Partners and program directors identified similar challenges
to using EBPs, including limited interventions for specific popula-
tions and difficulty adapting EBPs (16). The latter finding was un-
expected, because 89% of partners said they were totally or some-
what confident in their personal abilities to adapt EBPs. Fewer
were confident in their abilities to implement EBPs with fidelity,
which may be an aspect of adapting EBPs that some find challen-
ging. Partners also were less confident in evaluating the imple-
mentation and effectiveness of EBPs. To help address these know-
ledge gaps, CDC, the National Cancer Institute, the CCC National
Partnership, and other cancer control entities have developed we-
binars, trainings, and tools to help cancer control planners move
research into practice (10,27). Additional training may be needed
on selecting an EBP on the basis of its fit for a community and
strength of evidence; on adhering to set protocols, core elements,
and process steps for an EBP to maintain fidelity; and on evaluat-
ing interventions and campaigns that have been adapted.
In addition to the findings presented here, the contributions of
state, tribal, and territorial CCC coalitions and partnerships in cre-
ating and implementing cancer control plans have been reported
(3,10,12,13,28,29). Fewer studies have been published about part-
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ner involvement in EBP evaluation; thus, additional research is
needed in this area (10,30). Evaluation studies are crucial to build-
ing the evidence base for EBPs.
This study has at least 3 limitations. First, only 53% of referred
CCC partners participated. The partners were affiliated with vari-
ous entities (eg, national health organizations, community-based
organizations, health care providers, health departments, academ-
ic medical centers), but some groups may not have been represen-
ted. Second, pilot testing a survey may not adequately verify its
validity and reproducibility. Third, limiting our sample to partners
involved in implementing cancer control plans may have intro-
duced a selection bias that affected the rating of the survey ques-
tions. We were interested in this subset of coalition members be-
cause they could respond to questions about using cancer-related
interventions on the basis of their experience. Social desirability
bias also may have been introduced if respondents did not answer
questions according to their true beliefs. However, our results help
expand our understanding of CCC partners’ roles in using EBPs
and can guide ongoing efforts to promote their use and dissemina-
tion for cancer control.
CCC encompasses the cancer continuum (eg, prevention, early de-
tection and diagnosis, treatment, survivorship, end of life); there-
fore, the context of cancer control (public health, primary care,
specialty care) influences the mechanisms by which EBPs are dis-
seminated and implemented (15). Public health and clinical com-
munities were represented in our study. Their perspectives on the
benefits of using EBPs support the continued use of evidence-
based approaches to guide efforts to reduce the burden of cancer.
The challenges of using EBPs that they identified highlight the
need to improve strategies to translate cancer prevention and con-
trol research into practice in real-world settings and for diverse
populations.
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Tables
Table 1. Respondent Characteristics, Survey of Uptake of Evidence-Based Practices Among National Comprehensive Can-
cer Control Program (NCCCP) Partners (n = 83), 2012a
Characteristic n (%)
Involved with CCC grantee as
Representative of an organization 76 (91.6)
Individual 7 (8.4)
Highest level of education completed
High school graduate/GED 1 (1.2)
Technical or vocational school 1 (1.2)
Some college 3 (3.6)
College graduate 24 (28.9)
Graduate or professional degree 54 (65.1)
Graduate/professional degree in public health/medical field
Yes 44 (81.5)
Length of time working with CCC program, y
<1 1 (1.2)
1–3 17 (20.5)
4 or 5 18 (21.7)
>5 47 (56.6)
Core activity for using EBPs with CCC program
Identifying interventions 66 (80.5)
Adapting interventions 67 (81.7)
Implementing interventions 75 (90.4)
Evaluating interventions 68 (81.9)
Totally or somewhat confident in personal ability to . . .
Assess appropriateness of EBPs for your jurisdiction 76 (91.6)
Find potential EBPs for CCC program in your jurisdiction 75 (90.4)
Adapt EBPs for specific populations or settings 74 (89.2)
Evaluate implementation and effectiveness of EBPs 70 (84.3)
Implement EBPs with fidelity 69 (83.1)
Abbreviations: CCC, comprehensive cancer control; EBPs, evidence-based practices; GED, general equivalency development.
a Because of missing data or nonresponse, denominators for some categories did not total 83.
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Table 2. Characteristics Rated as Very Important When Selecting Evidence-Based Practices (EBPs)a Among National Com-
prehensive Cancer Control Program (NCCCP) Partners (n = 83), 2012b
Characteristic n (%)
Consistent with our organization’s mission 74 (89.2)
Cost-effective 68 (81.9)
Scientific evidence saying it works 65 (78.3)
Easy to implement 60 (72.3)
Available for free or low cost 57 (68.7)
Easy to evaluate 52 (62.7)
Easily adaptable 51 (61.4)
Encouraged by funders 36 (43.4)
Other organizations like ours are using it 33 (40.2)
People in our community requested it 32 (38.6)
Technical assistance is available 26 (31.3)
Innovative 22 (26.8)
We had used it before 11 (13.3)
Lack of alternatives 9 (10.8)
a The question was, “In general, how important are each of the following factors to your CCC program when choosing an EBP?”
b Because of missing data or nonresponse, denominators for some categories did not total 83.
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Table 3. Perceived Organizational Capacity for Using Evidence-based Practicesa Among National Comprehensive Cancer
Control Program Partners (n = 83), 2012b
Strongly agreed or agreed with statement n (%)
My CCC organization understands the importance of using EBPs 64 (84.3)
My CCC organization has adequate access to cancer registry data 56 (74.7)
Using EBPs is part of the norm in my CCC organization 56 (74.7)
My CCC organization has community members who can advise us on EBPs 54 (71.0)
My CCC organization has sufficient access to epidemiological expertise 52 (68.4)
My CCC organization has sufficient data support to inform our cancer control planning 51 (67.1)
My CCC organization has a champion who supports the use of EBPs 51 (67.1)
My CCC organization has sufficient staff in place to implement EBPs 37 (48.7)
My CCC organization has sufficient staff in place to develop new EBPs 21 (27.7)
My CCC organization has sufficient financial resources to implement existing EBPs 18 (23.7)
My CCC organization has sufficient financial resources to develop new EBPs 6 (7.9)
Abbreviations: CCC, comprehensive cancer control; EBP, evidence-based practice.
a The question was, “Please indicate your level of agreement with the following statements.”
b Because of missing data or nonresponse, denominators for some categories did not total 83.
PREVENTING CHRONIC DISEASE VOLUME 12, E113
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY           JULY 2015
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2015/15_0095.htm • Centers for Disease Control and Prevention       9
